Polygenic score
Influential genes: ALPL,SLC22A2,RGS14
Variants in the ALPL gene can potentially affect the body's metabolism of phosphate-containing compounds and contribute to the development of kidney stones.
The gene SLC22A2 encodes a protein involved in the transport of organic ions in the kidneys. Variations in this gene could potentially impact kidney function, which might also influence the risk of kidney stones.
A study conducted on the Chinese Han population found that genetic polymorphisms in the RGS14 gene were significantly associated with renal stone disease (RSD).
Kidney stones are hard deposits made from minerals and salts in the urine that can cause an obstruction of the kidney as well as any other part of the urinary system. Usually, there are many waste products dissolved in the urine, but if the amount increases above the physiological value, due to many reasons (such as diet, not drinking enough water, excessive body weight, certain medical conditions, or medications), crystals begin to form. The formation is facilitated by states of dehydration. Most of those crystals get excreted via the urinary system and don't cause any problems, but they can form bigger structures over time. The passage of those stones begins to be problematic and patients can experience severe pain, often described as the worst pain one can feel. The chance of a 1 cm stone passing is around 10% and stones over 1 cm usually don't pass at all. If the passage isn't possible anymore, the stones can obstruct any part of the urinary system and restrict urine elimination, which can lead to the development of infections and other complications. When the excretion of the stones isn't possible naturally, even with medical help, intervention is inevitable.
Kidney stones are a very common health condition affecting almost 15% of the world's population and the numbers continue to increase. It's estimated that half of the patients dealing with kidney stones will experience them again in the next 5 years.[1]
There are many risk factors for the development of the disease:
Research into the causes of kidney stones has looked at both individual genetic factors and a combination of genetic influences. These factors involve different conditions and pathways that together contribute to the development of kidney stones. Some of these contributors include conditions like hypocitraturia and hypomagnesemia, as well as primary hyperoxaluria.[3,4]
While the study of single genetic variants has faced some challenges, scientists have found connections between over 30 genes and kidney stones. However, it's important to understand that these genetic changes are only confirmed in about 15% of cases. This suggests that most cases are influenced by a combination of multiple genes, rather than just one.[5]
Genetic testing gives us the opportunity to discover whether you have a predisposition to developing this disease. At Macromo, we use polygenic risk scores and causative evidence-based genetic variants foe evaluation. The polygenic risk score (PRS) represents the total number of genetic variants that increase an individual's risk of developing a particular disease. All variants across their genome are summed and ranked according to their effect on disease development.
As kidney stones increase in size, patients begin to notice symptoms with different severity.
Diagnosis of kidney stones starts with a medical history and physical examination. It's necessary to settle the size and location of the stones, therefore imaging methods are indicated. The main method used for diagnosis is a CT scan. After gathering information about the stone, it's important to assess patients' general health. Blood tests are indicated to evaluate the state of the kidneys and to find the possible underlying cause (such as elevated lipid levels or medical conditions).
The goal of kidney stones therapy is to allow the passing of the stones without surgery. Patients are instructed to drink high amounts of water and adhere to recommended treatment in managing pain and nausea. It is possible to prescribe ureter relaxing medicines, most commonly tamsulosin (sold as Flomax). If the stones are too big and cause a blockage or infection, intervention is unfortunately inevitable. There are many approaches, including invasive and non-invasive methods:
It's important to assess any known health condition and adhere to its treatment to prevent recurrence of the kidney stones.
There are plenty of factors increasing the risk of developing kidney stones, but luckily enough, a lot of them are modifiable. What are the steps that can help you significantly decrease the risk?
In general, the prognosis of kidney stones is very positive, although there is a high possibility of recurrence. Therefore it's important to assess any possible source of origin and adhere to lifestyle changes and recommended medications. In 80 to 90%, kidney stones pass on their own and no treatment is needed.[6] The surgical approach to the removal of larger kidney stones is in general very successful and the recovery time is very short. If larger stones aren't removed, the urine buildup could lead to infections and subsequent kidney failure. Kidney stones also increase the risk of developing chronic kidney disease.
Get the guidelines for a healthier and longer life. With Macromo tests, you'll learn your health risks and how to prevent them.
Continue to Shop